Market revenue in 2023 | USD 68,243.3 million |
Market revenue in 2030 | USD 79,993.9 million |
Growth rate | 2.3% (CAGR from 2023 to 2030) |
Largest segment | Clinical chemistry |
Fastest growing segment | Human & Tumor Genetics |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Human & Tumor Genetics, Clinical Chemistry, Medical Microbiology & Cytology, Other Esoteric Tests |
Key market players worldwide | Labcorp Holdings Inc, Qiagen NV, Eurofins Scientific SE, Quest Diagnostics Inc, OPKO Health Inc, Siemens Healthineers AG ADR, NeoGenomics Inc, Fresenius Medical Care AG, Sonic Healthcare Ltd, Charles River Laboratories International Inc, SYNLAB Group, Mayo Clinic |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical laboratory service market will help companies and investors design strategic landscapes.
Clinical chemistry was the largest segment with a revenue share of 51.17% in 2023. Horizon Databook has segmented the Europe clinical laboratory service market based on human & tumor genetics, clinical chemistry, medical microbiology & cytology, other esoteric tests covering the revenue growth of each sub-segment from 2018 to 2030.
Several initiatives are undertaken by government and private organizations to fund R&D pertaining to clinical laboratory tests & services and create awareness about early diagnosis, which is expected to boost the Europe clinical laboratory services market.
Clinical laboratory services in Europe are expected to grow at a significant rate due to efforts of government organizations, such as the European Organization for Research and Treatment of Cancer (EORTC), the European Medicines Agency (EMA), and NHS, which plan to develop a unique program focusing on multiple approaches for improving the diagnosis in the region.
The COVID-19 pandemic significantly impacted the European market and various public organizations in the country mandated testing regardless of individuals showing symptoms. This improved the diagnosis rate in the country.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe clinical laboratory service market , including forecasts for subscribers. This continent databook contains high-level insights into Europe clinical laboratory service market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account